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Available online 28 January 2014Abstract Embryonic stem cells (ESCs) are promising resources for clinical therapies due to their potential to generate
multiple cell types. The dynamic expression of de novo methyltransferases (Dnmt3a and Dnmt3b) is essential to ESCs; however,
the regulatory mechanism of Dnmt3a or Dnmt3b expression in ESCs is still poorly understood. Here, we reported that decreased
expression of microRNA-495 (miR-495) in the first 2 days of embryoid body (EB) formation was required for mouse embryonic
stem cell (mESC) differentiation because repressed mesoderm and endoderm lineages were detected in ectopic miR-495
expression mESCs. This effect was reversed by the function blockade of miR-495. We identified Dnmt3a as a functional target of
miR-495 and showed that endogenous miR-495 repressed the expression of Dnmt3a in mESCs. Furthermore, the effect of
miR-495 on mESCs could be eliminated by Dnmt3a overexpression. Moreover, miR-495 had no effect on the expression of
Dnmt3b despite the findings obtained from previous studies that mainly focused on the common characteristics of the
regulatory mechanisms of Dnmt3a and Dnmt3b expression. Thus, our studies not only uncovered a previously uncharacterized
function of miR-495 in mESC differentiation but also generated a new idea to explore the mechanisms governing the functional
difference between Dnmt3a and Dnmt3b.
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Derived from the inner cell mass (ICM) of blastocysts,
embryonic stem cells (ESCs) have the ability to rapidly
proliferate in the same state (self-renewal) (Smith, 2001;
Czyz et al., 2003). Another key feature of ESCs is their capacity
to differentiate into multiple cell lineages (pluripotency),
which makes it a valuable tool for clinical therapies. It isan open access article under the CC BY-NC-ND license
551Repression of mesendoderm by the miR-495-Dnmt3a axisfeasible to replace the damaged cells or organs with healthy
ones that have been differentiated from ESCs. Mouse
embryonic stem cells are one ideal research model used to
study the molecular basis underlying ESC pluripotency and the
mechanism controlling lineage specification. Because mouse
ESCs (mESCs) can differentiate into ectoderm, mesoderm
and endoderm progenitors, how it chooses between these
different cell fates has become an increasingly attractive
area of research. A large number of elements regulating cell
fate choice have been identified, including transcription
factors (Oct4, Sox2, Myc, TAF3, etc.) (Smith et al., 2010;
Thomson et al., 2011a; Niwa et al., 2000), signaling pathways
(BMP, Wnt, Stat3, TGF pathways, etc.) (Ying et al., 2003; Ten
et al., 2011; Mahmood et al., 2010) and chromatin remodeling
enzymes (Dovey et al., 2010).
Previous studies have suggested that the de novo DNA
methyltransferases 3a and 3b (Dnmt3a and Dnmt3b) are
essential for proper mammalian development (Okano et al.,
1999; Feng et al., 2005). The Dnmt3a-deficientmouse displays
a malfunction of the gut, spermatogenesis defects and
postnatal lethality at 4 weeks after birth (Okano et al.,
1999). The Dnmt3b knockout mouse demonstrates neural tube
defects and is embryonically lethal at E14.5–E18.5 (Okano et
al., 1999). Induced pluripotent stem cells (iPS cells)
(Takahashi et al., 2007) derived from Dnmt3a and Dnmt3b
knockout mouse embryonic fibroblasts (MEFs) demonstrate
restricted developmental potential (Pawlak and Jaenisch,
2011). During ESC early lineage specification, Dnmt3a and
Dnmt3b are necessary to suppress the expression of
pluripotency factors (such as Oct4 and Nanog), resulting in
the initiation of differentiation (Li et al., 2007). ESCs in the
absence of the activities of Dnmt3a and Dnmt3b lose their
capacity to differentiate with cell passage (Chen et al., 2003).
Although many studies have focused on the methylation
activities or the value of Dnmt3a and Dnmt3b in ESC
pluripotency, it is still unclear how the functions of Dnmt3a
and Dnmt3b are controlled. Furthermore, evidence suggests
that the expression pattern of Dnmt3a and Dnmt3b is not
identical and that the functions of Dnmt3a and Dnmt3b may
not be the same because neither Dnmt3a nor Dnmt3b
knockout mice show different developmental defects (Okano
et al., 1999); however, the different regulatory mechanisms
between these two molecules are yet to be investigated.
In addition to these transcriptional regulations, evidence
suggests that microRNAs (miRNAs) play an important role in
controlling ESC early germ layer differentiation (Marson et
al., 2008; Xu et al., 2009; Tay et al., 2008; Ivey et al., 2008).
MiRNAs decrease the expression of genes at the mRNA level
or protein level by binding to partially complementary sites
in mRNA 3′ untranslation regions (3′ UTR) (Bartel, 2004).
Because target genes can be found among the core factors
of the pluripotency regulation network, miRNAs are involved
in modulating these cellular development processes, similar
to transcription factors (Zhao and Srivastava, 2007). Dicer
or DGCR8 (key enzymes in the miRNA maturation process)
knockout mice demonstrate a loss of most miRNAs and, con-
sequently, display defects in differentiation (Wang et al.,
2007; Kanellopoulou et al., 2005). In addition, an abundance
of miRNAs relating to ESCs has been reported, including the
cell type-specific expression of miRNAs (Wang et al., 2009)
and miRNAs having different expression levels between ESCs
and differentiated ESCs (Morin et al., 2008). However,knowledge regarding the global function of specific miRNAs
in the regulation of early lineage selection of ESCs is still
poor.
The Dlk1-Dio3 imprinted domain is a gene cluster including
the paternally inherited protein-coding genes, Dlk1, Rtl1 and
Dio3, as well as maternally inherited noncoding RNA genes (Da
et al., 2008). Studies have indicated that the Dlk1-Dio3 gene
cluster is required for a broad range of development process,
such as postnatal neurological growth and differentiation of
tissues (Tevendale et al., 2006; Georgiades et al., 2000).
MiR-495 is among the miRNA gene cluster of the Dlk1-Dio3
domain (Seitz et al., 2004). Previous reports have examined
the function of miR-495 in cancer (Hwang-Verslues et al.,
2011; Jiang et al., 2012). For the first time, we identified
miR-495 as an inhibitor at the early stage of mesendoderm
lineage selection from mESCs. Using gain-of-function and
loss-of-function approaches, we found that miR-495 partici-
pates in the global mesoderm and endoderm lineage gene
expression and that miR-495 function was achieved via the
specific targeting of Dnmt3a.
Materials and methods
Cell culture and in vitro differentiation by embryoid
body (EB) formation
mESCs (E14T) were cultured feeder-free on a 0.1% gelatin-
coated plate in high glucose DMEM (Hyclone) containing 15%
(v/v) FBS (Gibco), 2 mM L-glutamine (Hyclone), 100 μM non-
essential amino acids (Hyclone), 55 μM 2-mercaptoethanol
(Gibco) and leukemia inhibitory factor (LIF, Millipore,
1000 U/ml). The cells were fed with fresh medium every
day and passaged every 2–3 days by using 0.25% trypsin/
EDTA (Gibco). In the EB formation differentiation assay,
2 × 105 cells were suspended in a 60-mm bacterial plate in
ESC medium without LIF. The medium was changed every
day and a portion of the cells was discarded to maintain the
proper density. At day 4, the EBs were collected for gene
expression analysis or seeded onto a gelatin-coated 48-well
plate for another 6 days for immunostaining. The 293FT
cell line was maintained in high glucose DMEM supplement-
ed with 10% FBS.
mESCs transfection and infection
Mimics and inhibitors (purchased from RiboBio, Guangzhou,
China, http://www.ribobio.com/) were transfected into
mESCs at a final concentration of 50 μM using FuGENE HD
(Roche Diagnostics, Basel, Switzerland, http://www.roche-
applied-science.com) according to the manufacturer's in-
structions. The cells were transfected every 2 days for
long-term experiments. For lentivirus preparation, foreign
DNA (4 μg) was transfected into 293FT cells together with the
packaging plasmids, PAX2 (3 μg) and VSVG (2 μg). Superna-
tant containing the lentivirus was added to the mESCs, which
were dissociated into single cells with supplement of FBS
(15%, v/v), LIF (1000 U/ml) and polybrene (8 μg/ml), and
replaced with fresh medium after 12 h. To establish the
Dnmt3a or Dnmt3b knockdown cell line, we infected mESCs
with virus-containing supernatant and then selected positive
cells using puromycin. In the rescue experiments, the mESCs
552 D. Yang et al.were infected with virus at 24 h after transfection with either
mimics or inhibitor, and the cells were then suspended to
form EBs at day 4 after infection.
The Dnmt3a overexpression plasmid (lenti-Dnmt3a) was
generated by cloning the Dnmt3a coding region into the
FUGW vector. The mutant form of Dnmt3a (mutENV-A) was
obtained using the QuickChange Lightning Multi Site-Directed
Mutagenesis Kit (Agilent Technologies), and mutagenesis
was confirmed by sequencing. To construct shDnmt3a or
shDnmt3b, 21-base pair Dnmt3a or Dnmt3b-specific regions
(shDnmt3a, GTGCAGAAACATCGAGGACAT; shDnmt3b, AAGT
GGAAAAGTACATTGCCT) for RNA interference were designed
and cloned into the pLKO.1-TRC cloning vector. The mature
sequences of miR-495 were synthesized and cloned into the
FUGW vector to generate miR-495 overexpression vector.
MiR-495 sponge with 3 bulged binding sites was constructed as
described previously (Ebert et al., 2007).
RNA extraction and quantitative real-time PCR
(QRT-PCR)
Total RNA was extracted using RNAiso plus (TaKaRa Bio Inc,
Japan) and was subsequently used to synthesize cDNA using
PrimeScript RT reagent kit (TaKaRa). QRT-PCR analysis was
performed using the SYBR Green qPCR Master Mix (Bio-Rad).
We measured the miRNA levels using the Bulge-Loop™miRNA
qPCR Primer Set (RiboBio) according to the manufacturer's
instructions.
Western blotting
The cells were washed twice with ice-cold phosphate-
buffered saline (PBS) and incubated on ice for 30 min with
RIPA lysis buffer (Beyotime, Shanghai, China, http://www.
beyotime.com/). Protein concentrations were measured using
the Pierce BCA Protein Assay Kit (Thermo). Primary antibodies
including anti-Oct4 (Santa Cruz Biotechnology), anti-Nanog
(Abcam), anti-Dnmt3a (Cell Signaling), anti-Dnmt3b (Cell
Signaling) and anti-GAPDH (Sigma) were used in this study.
Immunostaining
In the immunostaining assay, the cells were washed with
PBS, fixed with 4% paraformaldehyde for 20 min and then
permeabilized with 0.2% Triton X-100 for 8 min. The cells
were blocked for 45 min in 10% FBS (v/v in PBS) and
incubated overnight with primary antibodies at 4 °C. Next,
the cells were stained with fluorescent secondary antibodies
for 2 h and Hoechst 33342 dye for 30 min. The cells were
observed using a fluorescence microscope. Primary antibod-
ies used in the mESC differentiation assay included anti-Tuj1
(Covance), anti-Gata4 (Santa Cruz Biotechnology) and
anti-AFP (Dako).
Luciferase assay
Luciferase reporters were generated by cloning the wild-type
Dnmt3a 3′ UTR into pGL3-basis vectors. Vectors with mutant
UTR were obtained using the QuickChange Lightning Multi
Site-Directed Mutagenesis Kit (Agilent Technologies). 293FTcells were transfected into 24-well with 50 nM mimics in
combination with 0.5 μg pGL-3 vector, 10 ng Renilla control
vector and FuGEN HD reagent. The luciferase activities were
examined using the Dual-Luciferase Reporter Assay System
(Promega).
Cell proliferation assay and flow cytometry analysis
of the cell cycle
For cell proliferation analysis, 4 × 104 cells were seeded into
6-well plates and the total number of cells was quantified at
24, 48 and 72 h post-seeding.
For cell cycle analysis, single-cell suspensions were
obtained using 0.25% trypsin/EDTA, washed with PBS, fixed
in 70% ethanol, re-centrifuged in PBS and then treated for 1 h
with RNase A (0.2 mg/ml) and for 10 min with PI (10 μg/ml).
FACS analysis was performed using a cytometer at 488 nm.
Teratoma formation
mESCs were trypsinized and resuspended at a concentration
of 2 × 106 cells/200 μl and then injected into athymic nude
mice (NOD-SCID) obtained from the National Resource Center
of Mutant Mice Model Animal Research Center (NARC), NJU.
After 4 weeks, tumors were harvested for qRT-PCR analysis of
differentiation markers.
DNA methylation analysis by bisulfite sequencing
Genomic DNA was isolated from cells and subjected to
bisulfite conversion with an EZ DNA Methylation-Gold Kit
(Zymo Research, USA) according to the manufacturer's
instructions. Target sequences of bisulfite-modified were
amplified by nested PCR, and five clones for each sample
were randomly picked and sequenced. CpG islands in the
promoters of mesendoderm markers were predicted using
MethPrimer (http://www.urogene.org/methprimer/). Primer
sequences were listed in Supplementary Table S1.
Statistical analysis
Student's t-test (two-tailed) was used to detect the
statistical significance, and the error bar represents the
standard error of mean (SEM) of three or more independent
experiments.
Results
MiR-495 inhibits mesoderm and endoderm lineage
specification during mESC differentiation
To clarify the function of miRNA located at the Dlk1-Dio3
domain during early mESC lineage specification, we focused
on the process of mESC differentiation by embryoid body
(EB) formation. The downregulation of Oct4 and Nanog
suggested that mESCs left the pluripotent state and initiated
lineage selection (Fig. S1A and B). To explore the expression
level of miR-495 in mESCs, we presented miR-290a-5p,
which was abundant in mESCs as control miRNA and the
abundance of miR-495 in mESCs was relative to miR-290a-5p.
Figure 1 MiR-495 represses mesoderm and endoderm lineage commitment during mESC differentiation by EB formation.
(A) QRT-PCR analysis showed that miR-495 expression temporarily decreases during EB differentiation. The abundance of miR-495 in
mESCs was relative to miR-290a-5p. SnoRNA U6 was used as an internal control for normalization. (B) The relative mRNA levels of the
differentiation markers in miR-495-overexpressed mESCs. Ectoderm markers, Nestin, Pax6, Sox1, Otx2, Fgf5; mesoderm markers,
Gata4, Gsc, Mesp1, Brachyury (T), Bmp4, Lhx1; endoderm markers, Gata6, Sox17, Cxcr4, Lamb1. (C) Immunostaining of the three
germ layer markers showed increased ectoderm (Tuj1) lineage commitment, decreased mesoderm (Gata4) and endoderm (Afp)
differentiation after miR-495 overexpression in mESCs. (D) The percentage of positive cells for the ectoderm, mesoderm and
endoderm lineage markers. (E–G) Increased mesoderm and endoderm differentiation in mESCs after transfection with the miR-495
inhibitor. GAPDH was used as an internal control for normalization in qRT-PCR. Hoechst 33342 (Ho.33342) was used for nucleus
staining (blue). Scale bar =100 μm. The error bar represents the SEM of three independent experiments (n = 3). *p b 0.05, **p b 0.01,
***p b 0.001.
553Repression of mesendoderm by the miR-495-Dnmt3a axisInterestingly, we observed that the miR-495 levels displayed
a temporary subsidence once differentiation was initiated
(approximately 50% reduction at day 1) and that miR-495
had the lowest expression level at day 2 (Fig. 1A).Thus, we sought to determine whether the decrease in
miR-495 expression levels during EB formation was essential
for normal mESC differentiation. To assess the functional
role of miR-495 in modulating mESC differentiation, we
554 D. Yang et al.transfected mESCs with miR-495 mimics, which are synthetic
mature miRNAs. Mimics with no homology to the mouse
genome were used as a negative control (control mimics) to
exclude nonspecific effects. Because miR-495 expression
exhibited a marked subsidence at very early stages, we
examined the expression of lineage-specific genes at day 4 in
miR-495- and control mimics-transfected mESCs under differ-
entiation conditions using qRT-PCR. Overexpression of
miR-495 in miR-495 mimics-transfected mESCs at day 4 during
differentiation was detected (Fig. S1C). In the presence
of miR-495 overexpression, both mesoderm lineage markers
[Gata4, Gsc, Mesp1, Brachyury (T), Bmp4, Lhx1] and
endoderm lineage markers (Gata6, Sox17, Cxcr4, Lamb1)
were repressed, while the partial ectoderm lineage markers
(Pax6, Sox1, Otx2, Fgf5) were upregulated (Fig. 1B). By
immunostaining at day 10, miR-495 mESCs displayed a
significant decrease in the mesoderm marker and endoderm
marker, Gata4 and α-fetoprotein (Afp), respectively, while
expression of the ectoderm marker β-III tubulin (Tuj1)
increased (Fig. 1C and D).
Next, we investigated the loss-of-function effect of miR-495
in the differentiation process by transfecting mESCs with the
miR-495 inhibitor, which was designed to specifically bind to
and inhibit endogenous miR-495. A sequence selected from
Caenorhabditis elegans, which had a minimum homology to the
human, mouse and rat genome, was used as a negative control
(control inhibitor). Similar to miRNA sponge, miRNA inhibitors
can sequester endogenous miRNA without affecting miRNA
expression (Fig. S1C). Under conditions of differentiation,
compared to the control inhibitor-transfected group, the
miR-495 inhibitor-transfected mESCs at day 4 demonstrated
a significant increase in the representation of the differentia-
tion markers of mesoderm and endoderm lineages, while
the ectoderm makers remained unchanged (Fig. 1E). Using
immunostaining analysis, miR-495 inhibitor-transfected mESCs
showed accumulated expression of mesoderm (Gata4) and
endoderm (Afp) marker at day 10 (Fig. 1F and G). On the basis
of all the results above, we concluded that miR-495 selectively
repressed the mesoderm and endoderm (mesendoderm) line-
age commitment at a very early stage of mESC differentiation.
Furthermore, we explored the functional role of miR-495
in modulating mesendoderm differentiation in vivo by
teratoma formation approach. Consistent with studies in
vitro, in the presence of miR-495 upregulation (Fig. S1D),
mesendoderm markers (except Gsc and Mesp1) were re-
pressed (Fig. S1E) and the miR-495 sponge significantly
increased most mesendoderm genes (Fig. S1F).MiR-495 minimally affects mESC self-renewal
Although miR-495 showed a repressive effect on the mESC
mesendoderm differentiation potential, we did not observe a
clear impairment of mESC self-renewal. Exogenous miR-495
expression was detected in mESCs (Fig. S2A). mESCs trans-
fected with either miR-495 or control mimics demonstrated no
obvious difference in the expression of pluripotency markers,
as shown at both the mRNA and protein levels (Fig. 2A and
S2B). After transfection for 4 days, immunostaining of
pluripotency markers, including Oct4, Nanog and SSEA1, also
showed no difference between the two groups (Fig. 2B).
Furthermore, we transfected mESCs with miR-495 or controlmimics every 2 days to assess the long-term effect, and mESCs
maintained domed colony structures without any morpholog-
ical changes (Fig. 2C). In addition, proliferation and cell cycle
analysis showed no clear difference between miR-495- and
control mimics-transfected mESCs (Fig. 2D and E). Moreover,
consistent results were obtained in the miR-495 loss-of-
function studies (Figs. 2A–E and S2B).MiR-495 specifically regulates Dnmt3a in mESCs
As noncoding genes, miRNAs regulate developmental
processes by targeting functional protein genes (Tay et al.,
2008). Using target prediction tools, we revealed Dnmt3a as
a promising candidate target of miR-495 (Fig. 3A). Although
the miR-495 expression levels were greatly decreased
(Fig. 1A), we found a rapid increase in the expression of
Dnmt3a during mESC differentiation (Figs. 3B and S3), which
was consistent with a previous study (Chen et al., 2002). This
finding further suggested that miR-495 and Dnmt3a may play
opposing roles in this process. Moreover, a critical role of
Dnmt3a might also involve the global repressive effect of
miR-495 in mESC differentiation.
To investigate whether Dnmt3a functions as a functional
target of miR-495 in mESCs, we constructed luciferase
reporter constructs that contain either wild-type 3′ UTR of
Dnmt3a or a mutant Dnmt3a with a 6-bp antisense mismatch
within the target site. Two reporters (Segment-S1 and
Segment-S5) were used that contained the corresponding
predicted targets (Fig. 3A). In 293FT cells, the luciferase
reporters were co-transfected with miR-495 or control
mimics. The miR-495 mimics significantly reduced the
luciferase activities of the wild-type Dnmt3a reporters,
while the mutant reporters were not repressed by miR-495
(Fig. 3C). Furthermore, a combination of the miR-495
inhibitors with the mimics inhibited the repression of the
luciferase activities by miR-495 mimics (Fig. 3C). Taken
together, these results suggested that Dnmt3a was a direct
target of miR-495.
We further validated the role of miR-495 in repressing
Dnmt3a in mESCs. Endogenous Dnmt3a expression was
significantly inhibited by miR-495 mimics but enhanced by
miR-495 inhibitor at both the mRNA and protein levels
(Fig. 3D and E). To test whether endogenous miR-495
can regulate endogenous Dnmt3a in mESCs, we over-
expressed Dnmt3a 3′ UTR to sequester endogenous miR-
495. A luciferase reporter vector without a 3′ UTR was used
as negative control. The Dnmt3a transcript levels were
increased in the presence of wild-type UTR (Fig. 3F), while
the Dnmt3a expression levels were not changed in mESCs
transfected with mutant 3′ UTR constructs. These findings
indicated that miR-495 modulated the expression of endog-
enous Dnmt3a in mESCs.
Interestingly, we observed no significant difference in the
Dnmt3b protein levels in the loss-of-function and gain-of-
function miR-495 studies (Fig. 3G), although Dnmt3b
expression pattern during mESC differentiation was similar
to Dnmt3a (Fig. S3) and previous studies have considered
both Dnmt3a and Dnmt3b as a single entity when investi-
gating their activities or regulatory mechanism (Okano et
al., 1999; Chen et al., 2002; Guo et al., 2013). In addition,
miR-495 has no predicted target sites in the Dnmt3b 3′ UTR.
Figure 2 MiR-495 has no obvious effect on mESC self-renewal. (A and B) Pluripotency marker genes showed no obvious difference
between the miR-495 mimics- or inhibitor-transfected cells compared to the control mimics (Ctrl mimics) or control inhibitor (Ctrl
inhibitor), respectively. Examination at the mRNA level was performed in cells at 48 h (p1) post-transfection, while the protein level
of Oct4, Nanog and SSEA1 were observed in (passage 2) mESCs using immunostaining assay. Scale bar = 50 μm. (C) mESCs transfected
with miR-495 mimics or inhibitor can be stably passaged with no morphological changes. mESCs were transfected every 2 days. p0,
cells transfected by mimics or inhibitors for 24 h; p2, passage 2, day 4 post-transfection; p5, passage 5, day 9 post-transfection. Scale
bar = 100 μm. (D and E) miR-495 mimics and inhibitor had no obvious effect on cell proliferation and cell cycle of mESCs. For the cell
proliferation analysis, 4 × 104 cells were seeded into 6-well plates (0 h) at 24 h post-transfection; total cell number was analyzed at
24, 48 and 72 h. mESCs were transfected with mimics or inhibitor for every 2 days. Cell cycle analysis was performed at p1 mESCs.
555Repression of mesendoderm by the miR-495-Dnmt3a axisThis evidence indicated that Dnmt3a and Dnmt3b might be
regulated by independent mechanisms, which suggested
that they may have different functions during development,
as previously reported (Okano et al., 1999). All of these
results demonstrated that miR-495 specifically targets
Dnmt3a in mESCs.Knockdown of Dnmt3a phenocopies miR-495
overexpression in mESCs
To understand the function of Dnmt3a in modulating
mESC differentiation, we performed loss-of-function assay
using a short hairpin RNA (shDnmt3a). Vector-containing
Figure 3 MiR-495 specifically targets Dnmt3a in mESCs. (A) Summary of the miR-495 target sites in the Dnmt3a 3′ UTR. The
underlined nucleotides were replaced with 6-bp antisense mismatches in the mutant UTR. Two reporter constructs (Segment-S1 and
Segment-S5) were designed and used. (B) A temporary increase in Dnmt3a in the differentiation of mESCs as assessed using EB
formation. (C) miR-495 repressed its targets in the luciferase reporter assay in 293FT cells. Firefly luciferase activity was normalized
to the control Renilla luciferase activity. (D and E) The mRNA and protein levels of Dnmt3a in mESCs transfected with miR-495 mimics
or inhibitor. (F) Increasing Dnmt3a levels in the presence of ectopic Dnmt3a wild-type 3′ UTR. One microgram of vector was
transfected into 5 × 104 mESCs and gene expression analysis was performed at 48 h. (G) The expression of Dnmt3b in miR-495 mimics-
or inhibitor-transfected mESCs. Abbreviations: WT, wild-type 3′ UTR of Dnmt3a; MT, mutant 3′ UTR of Dnmt3a. The error bar
represents the SEM of three independent experiments (n = 3). *p b 0.05, **p b 0.01, ***p b 0.001.
556 D. Yang et al.non-hairpin inserts were used as a negative control (pLKO.1-
TRC control). A reduction in Dnmt3a was confirmed in mESCs
(Fig. 4A). We established a stable Dnmt3a knockdown mESC
line by infecting mESCs with Dnmt3a-shRNA-containinglentivirus. We found that knockdown of Dnmt3a did not
affect the self-renewal of mESCs. Using qRT-PCR analysis, we
revealed that the expression levels of pluripotent markers
(Oct4, Nanog, Rex1 and Utf1) were indistinguishable between
557Repression of mesendoderm by the miR-495-Dnmt3a axisDnmt3a knockdown (shDnmt3a) and control knockdown
(PLKO) cell lines (Fig. 4B). Similar results were obtained by
confirming the protein levels of Oct4 and Nanog (Fig. S4A). The
shDnmt3a-mESC line can also be stably passaged with domed
colony morphology (Fig. 4C). In addition, cell proliferation and
cell cycle analysis showed no significant difference between
the shDnmt3a and PLKO cell lines (Fig. 4D and E). Taken
together, these findings suggested that Dnmt3a was not
necessary for mESC self-renewal, which was consistent withFigure 4 Dnmt3a-knockdown mESCs exhibit a similar phenotype t
in mESCs infected with the shDnmt3a lentivirus. PLKO, a cell line infe
Dnmt3a knockdown cell line. (B) The expression level of pluripote
compared to control cells. (C) Dnmt3a-knockdown mESCs can be sta
(D and E) The cell proliferation and cell cycle analysis showed no si
(F) Repressed mesendoderm and increased ectoderm differentiation
SEM of three independent experiments (n = 3). *p b 0.05, **p b 0.01previous reports (Tsumura et al., 2006). To explore the
function of Dnmt3a in mESCs at the early lineage specification
stage, we cultured shDnmt3a cells under differentiation
conditions and examined the expression of lineage-specific
markers at day 4. The depletion effect of Dnmt3a using
Dnmt3a-shRNA under differentiation conditions was confirmed
(Fig. S4B). After differentiation, the shDnmt3a cells displayed
a significantly lower expression of mesoderm and endoderm
lineage markers compared to PLKO cells, while ectodermo miR-495-overexpressed mESCs. (A) The attenuation of Dnmt3a
cted with lentivirus containing control pLKO.1-TRC; shDnmt3a, a
ncy markers in Dnmt3a-knockdown cell line showed no change
bly passaged. p3, passage 3; p8, passage 8. Scale bar =100 μm.
gnificant difference between the shDnmt3a and PLKO cell line.
in Dnmt3a-knockdown cell lines. The error bar represents the
.
558 D. Yang et al.marker expression was much higher in the shDnmt3a cells
(Fig. 4F). Taken together, Dnmt3a is required for the
normal differentiation process and inhibition of Dnmt3a
mimics the effect of miR-495 overexpression in mESCs cell-
fate decisions.
Furthermore, we explored the effect of Dnmt3b on mESC
early differentiation by performing loss-of-function assay
(Fig. S4C). Consistent with previous research (Tsumura et
al., 2006), shDnmt3b cells cultured in ESC medium showed
no effect on mESC pluripotent makers (Fig. S4D). At day 4 of
mESC differentiation, after knockdown of Dnmt3b, both the
ectoderm marker Pax6, Sox1, Fgf5 and the mesoderm maker
Gsc and Mesp1 were upregulated, while other mesoderm
maker downregulated and endoderm marker remained
unchanged (Fig. S4E). These results indicated the different
role of Dnmt3a and Dnmt3b in mESC early differentiation.
MiR-495 repressed mesendoderm specification via
direct targeting of Dnmt3a
The opposite expression pattern of miR-495 and Dnmt3a
(Figs. 1A and 3B) suggested a contrasting function in mESCs at
the early differentiation stage. To determine whether miR-495
repressed mesendoderm lineage specification by inhibiting
Dnmt3a expression levels, we performed rescue experiments
by introducing exogenous Dnmt3a (Fig. 5A) in miR-495-
overexpressed mESCs (Fig. S5A) or reducing the expression of
Dnmt3a (shDnmt3a) in miR-495 inhibitor-transfected cells (Fig.
S5B). Lineage-specific markers were examined in miR-495-
overexpressed cells with Dnmt3a added at day 4 under
differentiation conditions. In the presence of miR-495, mESCs
with ectopic Dnmt3a displayed a marked increase of both the
expression of mesoderm and endoderm markers compared to
control (Fig. 5B). Consistent results were obtained from
immunostaining at day 10 (Fig. 5C and D). Furthermore, a
decrease of Dnmt3a in miR-495-inhibited cells reversed the
increase of mesendoderm markers by miR-495 inhibitor
(Fig. 5E), and consistent conclusions were drawn by immuno-
staining (Fig. 5F and G). We also detected the ectoderm
markers (Fig. S5C and D) in rescue experiments. Thus, the
degradation of Dnmt3a by ectopic miR-495 resulted in a
miR-495-mediated decrease of mesoderm and endoderm-
specific markers. To investigate whether the repression of
mesendoderm markers by miR-495 was related to the DNA
methylation catalytic activity, we introduced a catalytically
inactive allele of Dnmt3a (mutENV-A) into rescue experiments
(Figs. 5A and S5A). This enzyme variant carried an E → A
exchange of the ENV glutamate in the conserved ENV motifs in
the catalytic center of Dnmt3a and had been reported to be
almost inactive (Reither et al., 2003). We observed that the
variant of Dnmt3a (mutENV-A) failed to restore most of
mesendoderm markers suppressed by miR-495 mimics (Figs.
5B and S5C), which suggested that the function of miR-495 in
mESC differentiation was mainly performed by affecting the
methyltransferase activity of Dnmt3a.
Discussion
MiR-495 belongs to a miRNA gene cluster at the Dlk1-Dio3
imprinted domain. Previous studies have shown that the
Dlk1-Dio3 region was essential for proper development anddisrupted expression of the entire noncoding RNA in
Dlk1-Dio3 region resulted in mouse embryonic lethality
(Tevendale et al., 2006; Georgiades et al., 2000). However,
the function of miRNAs among the Dlk1-Dio3 gene cluster in
embryonic development remains unclear. Here, we reported
a previously uncharacterized role of miR-495 in mESC cell
fate decisions. Elevated levels of miR-495 repressed the
mesoderm and endoderm (mesendoderm) lineage-specific
markers in mESC early differentiation, and these effects
were reversed in the presence of miR-495 inhibitor. These
results demonstrated that an individual miRNA within the
Dlk1-Dio3 region could regulate mESC lineage selection.
Recent studies (Stadtfeld et al., 2010; Liu et al., 2010)
have implicated the Dlk1-Dio3 region with reprogramming
since silence of this gene cluster in iPS cells resulted in
embryonic lethality. Moreover, some miRNAs of the Dlk1-Dio3
gene cluster even displayed no expression in iPS cells,
suggesting that miRNAs of the Dlk1-Dio3 locus might be
involved in the developmental potential, but not the self-
renewal ability of mESCs. In our study, we observed no
obvious effect of miR-495 on mESC self-renewal because cells
with miR-495 mimics or inhibitor could be stably passaged
without morphological changes, which was consistent with
previous reports. Interestingly, miR-495 demonstrated a
positive role in increasing ectoderm lineage specification.
However, blocking the function of miR-495 with the inhibitor
showed no significant effect on most ectoderm markers.
These findings suggested that a regulator might play a distinct
role in different processes, thereby stressing the complexity
of mESC lineage-specific regulation.
The mesendoderm lineage specification of ESCs is
essential for future therapeutic use of mesendoderm
progenitor-derived tissues and is controlled by numerous
factors. Mesoderm formation requires BMP4 signaling and is
induced by the interaction between the WNT and FGF
signaling pathways, while initial specification of the endo-
derm lineage requires Smad-mediated TGF-β signaling
[reviewed in (Loebel et al., 2003)]. Moreover, elevated
levels of Oct4 expression promote mesendoderm differenti-
ation while Sox2 displays the opposite effect (Thomson et
al., 2011b). Importantly, the formation of mesendoderm
progenitors within first 4 days during mESC differentiation is
essential for further mesoderm or endoderm lineage spec-
ification. However, the mechanism controlling the alloca-
tion of mESCs into mesendoderm and ectoderm is still not
completely understood. We observed decreased levels of
miR-495 within first 2 days of mESC differentiation and
miR-495 displayed a negative effect on mesendoderm
lineage gene expression, integrating miR-495 into the
regulatory circuitry that controls mesendoderm formation
during the early differentiation of mESCs.
Dnmt3a and Dnmt3b have been identified as de novo DNA
methyltransferases in the mouse, which display similar
structures and abilities to perform de novo methylation in
mammalian development (Okano et al., 1999). Methylation
of Oct4 and Nanog by Dnmt3a and Dnmt3b is necessary for
the initiation of differentiation, and teratomas differentiat-
ed from Dnmt3a- and Dnmt3b-deficient iPS cells have
abnormally differentiated mesodermal structures and few
endodermal-like structures (Pawlak and Jaenisch, 2011).
However, previous research (Okano et al., 1999) suggested
that Dnmt3a−/− mice died about 4 weeks of age and
Figure 5 MiR-495 inhibits mesoderm and endoderm differentiation of mESCs by repressing Dnmt3a. (A) The overexpression of
wild-type and mutant variant Dnmt3a in mESCs. FUGW, mESCs infected by FUGW-containing lentivirus. Dnmt3a, mESCs infected by
lenti-Dnmt3a-containing lentivirus. MutENV-A, mESCs infected by lentivirus containing Dnmt3a mutant variant with an E → A exchanges
of the ENV glutamate. (B–D) The repression of mESCs mesendoderm markers by miR-495 was reversed by ectopic expression of wild-
type Dnmt3a. The mRNA level of lineage-specific genes at day 4 in EB differentiation was analyzed using qRT-PCR. The error bar
represents the SEM of three independent experiments (n = 3). The asterisk (*) denotes a significance of difference from the combination
of control mimics with FUGW, and the hash mark (#) denotes a significant difference from the combination of miR-495 mimics with
FUGW. *,#p b 0.05, **,##p b 0.01, ***,###p b 0.001. The immunostaining assay and the percentage of positive cells in the lineage markers
analysis performed at day 10 in EB differentiation (C and D). (E–G) Increased mesendoderm differentiation by the miR-495 inhibitor was
abrogated by knockdown of Dnmt3a. The error bar represents the SEM of three independent experiments (n = 3). The asterisk (*)
denotes a significance of difference from the combination of control inhibitor with PLKO, and the hash mark (#) denotes a significant
difference from the combination of miR-495 inhibitor with PLKO. *,#p b 0.05, **,##p b 0.01, ***,###p b 0.001.
559Repression of mesendoderm by the miR-495-Dnmt3a axisDnmt3b−/− mice were embryonic lethal, indicating the
distinct function and regulatory mechanisms of Dnmt3a and
Dnmt3b which were still poorly understood.In the present study, we found that Dnmt3b displayed
different function in early lineage specification of mESCs
from Dnmt3a. The reduction of Dnmt3a expression in mESCs
560 D. Yang et al.caused similar cell fate phenotypes as miR-495 overexpres-
sion, and miR-495 directly repressed Dnmt3a but showed no
obvious effect on Dnmt3b. Consistent with our study,
another study observed a different expression pattern
between Dnmt3a and Dnmt3b and identified their functional
differences in the central nervous system development
(Feng et al., 2005). These results indicated a difference in
the regulatory mechanism between Dnmt3a and Dnmt3b
expression, in which epigenetic modulation by miRNAs might
play an important role, providing a novel idea to explore the
mechanisms governing the functional difference between
Dnmt3a and Dnmt3b. Furthermore, the effect of DNA
methylation activity of Dnmt3a on differentiation was
closely linked to miR-495 as the reduction of mesendoderm
differentiation by miR-495 was significantly rescued by wild-
type ectopic Dnmt3a but not mutENV-A variants in
miR-495-overexpressed mESCs. However, we detected no
changes in methylation status at the promoter regions of
mesendoderm genes when miR-495 activity was modulated
(Fig. S6), which suggested that these genes could be markers
of differentiation processes and indirectly modulated by
Dnmt3a. The direct targets of Dnmt3a in modulating mESC
mesendoderm differentiation remain to be further studied.
In conclusion, we found that miR-495 served as a global
repressor of mesoderm and endoderm lineages in mESC early
differentiation, and this effect was exerted by direct inhibition
of Dnmt3a. These findings enhanced our understanding of the
function of miRNAs in mESC lineage specification and would be
helpful to control mesoderm and endoderm differentiation in
further cell-based therapies. Furthermore, we observed that
miR-495 specifically repressed Dnmt3a with no effect on
Dnmt3b, which will not only contribute to exploring the
distinct function of Dnmt3a and Dnmt3b, but also guide future
research on mESC differentiation.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.01.005.
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